Angiomyolipoma with minimal fat: Can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?

Radiology

Volumn 265, Issue 2, 2012, Pages 468-477

  Hindman, Nicole ^a   Ngo, Long ^b   Genega, Elizabeth M ^b   Melamed, Jonathan ^a   Wei, Jesse ^b   Braza, Julia M ^b   Rofsky, Neil M ^c   Pedrosa, Ivan ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ANGIOMYOLIPOMA; ARTICLE; BLEEDING; COHORT ANALYSIS; COLLATERAL CIRCULATION; CONTROLLED STUDY; CYSTIC DEGENERATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY VEIN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; RETROPERITONEUM; RETROSPECTIVE STUDY; SEX DIFFERENCE; SIGNAL INTENSITY INDEX; SPLEEN; TUMOR NECROSIS; TUMOR TO SPLEEN RATIO; TUMOR VOLUME; VEIN THROMBOSIS;

ADENOCARCINOMA, CLEAR CELL; ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; ANGIOMYOLIPOMA; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MASSACHUSETTS; MIDDLE AGED; NEW YORK; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84867908753     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112087     Document Type: Article

References (35)

1. Fujii Y, Komai Y, Saito K, et al. Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 2008;72(3):598-602.
2. Schachter LR, Cookson MS, Chang SS, et al. Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients. J Endourol 2007;21(8):819-823. (Pubitemid 47443652)
3. Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P. Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 2006;176(6 Pt 1):2391-2395; discussion 2395-2396.
4. Milner J, McNeil B, Alioto J, et al. Fat poor renal angiomyolipoma: patient, computerized tomography and histological findings. J Urol 2006;176(3):905-909. (Pubitemid 44142557)
5. Bosniak MA, Megibow AJ, Hulnick DH, Horii S, Raghavendra BN. CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. AJR Am J Roentgenol 1988;151(3):497-501.
6. Catalano OA, Samir AE, Sahani DV, Hahn PF. Pixel distribution analysis: can it be used to distinguish clear cell carcinomas from angiomyolipomas with minimal fat? Radiology 2008;247(3):738-746.
7. Israel GM, Hindman N, Hecht E, Krinsky G. The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol 2005;184(6):1868-1872. (Pubitemid 40770162)
8. Pedrosa I, Sun MR, Spencer M, et al. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. RadioGraphics 2008;28(4):985-1003.
9. Zhang J, Pedrosa I, Rofsky NM. MR techniques for renal imaging. Radiol Clin North Am 2003;41(5):877-907. (Pubitemid 37152082)
10. Dunnick NSC, Amis E. Textbook of uroradiology. 2nd ed. Baltimore, Md: Williams & Wilkins, 1997.
11. Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology 2006;240(1):6-22. (Pubitemid 43902590)
12. Jinzaki M, Silverman SG, Tanimoto A, Shinmoto H, Kuribayashi S. Angiomyolipomas that do not contain fat attenuation at unenhanced CT. Radiology 2005;234(1):311; author reply 311-312.
13. Jinzaki M, Tanimoto A, Narimatsu Y, et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 1997;205(2):497-502. (Pubitemid 27467332)
14. Kim JK, Kim SH, Jang YJ, et al. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 2006;239(1):174-180.
15. Silverman SG, Mortele KJ, Tuncali K, Jinzaki M, Cibas ES. Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. RadioGraphics 2007;27(4):1131-1143.
16. Pedrosa I, Chou MT, Ngo L, et al. MR classification of renal masses with pathologic correlation. Eur Radiol 2008;18(2):365-375. (Pubitemid 351234058)
17. Low RN, Ma J, Panchal N. Fast spin-echo triple-echo Dixon: initial clinical experience with a novel pulse sequence for fat-suppressed T2-weighted abdominal MR imaging. J Magn Reson Imaging 2009;30(3):569-577.
18. Madhuranthakam AJ, Yu H, Shimakawa A, et al. T(2)-weighted 3D fast spin echo imaging with water-fat separation in a single acquisition. J Magn Reson Imaging 2010;32(3):745-751.
19. Outwater EK, Blasbalg R, Siegelman ES, Vala M. Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance. RadioGraphics 1998;18(6):1465-1480. (Pubitemid 128467071)
20. Krishnan B, Truong LD. Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum Pathol 2002;33(1):68-79. (Pubitemid 34112954)
21. Outwater EK, Bhatia M, Siegelman ES, Burke MA, Mitchell DG. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 1997;205(1):103-107. (Pubitemid 27415133)
22. Barth MM, Smith MP, Pedrosa I, Lenkinski RE, Rofsky NM. Body MR imaging at 3.0 T: understanding the opportunities and challenges. RadioGraphics 2007;27(5):1445-1462; discussion 1462-1464.
23. McKenzie CA, Lim D, Ransil BJ, et al. Shortening MR image acquisition time for volumetric interpolated breath-hold examination with a recently developed parallel imaging reconstruction technique: clinical feasibility. Radiology 2004;230(2):589-594. (Pubitemid 38133827)
24. Robson PM, Grant AK, Madhuranthakam AJ, Lattanzi R, Sodickson DK, McKenzie CA. Comprehensive quantification of signal-to-noise ratio and g-factor for image-based and k-space-based parallel imaging reconstructions. Magn Reson Med 2008;60(4):895-907.
25. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212(3):876-884. (Pubitemid 29410996)
26. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector. Radiology 1996;201(3):705-710. (Pubitemid 26392618)
27. Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A. Fat suppression in MR imaging: techniques and pitfalls. RadioGraphics 1999;19(2):373-382.
28. Hood MN, Ho VB, Smirniotopoulos JG, Szumowski J. Chemical shift: the artifact and clinical tool revisited. RadioGraphics 1999;19(2):357-371.
29. Firth D. Bias reduction of maximum likelihood estimates. Biometrika 1993;80(1):27-38.
30. Hafron J, Fogarty JD, Hoenig DM, Li M, Berkenblit R, Ghavamian R. Imaging characteristics of minimal fat renal angiomyolipoma with histologic correlations. Urology 2005;66(6):1155-1159. (Pubitemid 41797280)
31. Lane BR, Aydin H, Danforth TL, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol 2008;180(3):836-843.
32. Yoshimitsu K, Honda H, Kuroiwa T, et al. MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient-echo imaging. J Magn Reson Imaging 1999;9(4):579-585. (Pubitemid 29194298)
33. Roy C, Sauer B, Lindner V, Lang H, Saussine C, Jacqmin D. MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses. Eur Radiol 2007;17(1):193-200. (Pubitemid 46063044)
34. Yoshimitsu K, Irie H, Tajima T, et al. MR imaging of renal cell carcinoma: its role in determining cell type. Radiat Med 2004;22(6):371-376. (Pubitemid 40144012)
35. Sun MR, Ngo L, Genega EM, et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes-correlation with pathologic findings. Radiology 2009;250(3):793-802.